About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Phase III Acute Coronary Syndrome

NCT00831441·1012 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bristol-Myers Squibb

With

Pfizer
Duke Clinical Research Institute

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Acute coronary syndrome (ACS)
Clinically stable
Receiving standard of care for ACS

You may not be if

Severe hypertension
Active bleeding or high risk for major bleeding
Hemoglobin \< 9 g/dL

The record

StatusTerminated

PhasePhase 3

Taking part7,484

StartedMar 2009

UpdatedJan 27, 2016

Conditions

Acute Coronary Syndrome

Where1012

Uab Medical Center
Birmingham, Alabama, United States
University Of Alabama At Birmingham
Birmingham, Alabama, United States
Heart Center Research, Llc
Huntsville, Alabama, United States

Clareo Health | Phase III Acute Coronary Syndrome